Vilobelimab Reduces Mortality Risk in Patients With Severe COVID-19 Pneumonia
Vilobelimab is a monoclonal antibody which works to reduce the level of complement split factor C5a by preserving the membrane attack complex.
Diagnosis & Disease Information
Monkeypox MVA-BN Vaccine Elicits Durable Immunity for 2 Years With Single Dose
The MVA-BN vaccine, developed by Bavarian Nordic, was evaluated in a clinical trial.
Procalcitonin Predicts Recurrence or Death After Ventilator-Associated Pneumonia
Among 140 patients included in the analysis, 56.4% had serum procalcitonin levels of less than 0.5 ng/mL, while 43.6% had levels of 0.5 ng/mL or higher.
Novel Immunoassay Stratifies Between Bacterial, Viral Infections in Children
Researchers evaluated the accuracy of the BV score using data from pediatric patients with fever who presented at emergency departments or urgent care centers.
Vaccination Status Not Associated With Acute Thromboembolism Risk in COVID-19
A total of 1428 patients were included in the analysis, of whom 185 (13%) were vaccinated and 1243 (87%) were unvaccinated against COVID-19 infection.
Antibiotic Overuse Common in Children Hospitalized With COVID-19
Bacterial culture growth was reported in 13 (14%) patients, and 5 (5%) had urinary tract or bloodstream infections.
Preventive Interventions Are Needed for Invasive Extraintestinal E. coli Disease
The researchers aimed to describe the clinical profile of IED, as well as the pattern of AMR for causative E coli isolates.
Oral Capsule Effective as Fecal Microbiota Transplant Delivery Strategy
Rate of decolonization was highest for patients in the EGD group (85.7%), followed by those in the oral capsule (84.6%), colonoscopy (63.6%), and gastric tube (50%) groups.
Subcutaneous Lenacapavir Effective for Patients With Multidrug-Resistant HIV
During a median follow-up period of 73 (range, 13-111) weeks, 1 patient discontinued treatment with lenacapavir due to grade 1 nodule at the injection site.
Individuals With HIV and Cognitive Impairment at Increased Risk for COVID-19 Mortality
Research has shown that PLWH are at increased risk for cognitive disorders, including dementia. In addition, dementia is known to be a risk factor for COVID-19 mortality.
